Bharat Biotech’s Covaxin ‘well tolerated with no serious adverse events’

The findings of phase 1 clinical trial of the COVID-19 vaccine have appeared on medRxiv, a preprint server.
|
||||
You Might LikeRelated videos from verified sources
Related news from verified sources
|